When a horse cannot breathe, two medicines can open its narrowed airways quickly. But the treatment that lasts longer may also be the one that avoids problems with the heart and gut. Severe asthma is common and incurable in horses, affecting about fourteen percent in the Northern Hemisphere.

It blocks airflow through inflamed, narrowed airways filled with mucus and structural changes. When rapid relief is needed, medicines that open the airways can help. Think of the airways like a set of drinking straws: asthma squeezes them narrower, while these medicines relax the squeeze so air can move more freely.

One option, HBB, can speed up the heart and reduce movement in the intestines. Horses already struggling with asthma may be more vulnerable to those cardiovascular effects. By contrast, the study reports that inhaled salbutamol has a favorable safety profile for horses being treated for severe asthma.

The study set out to compare how strongly and how long the two medicines opened narrowed airways, while also comparing unwanted effects. The expectation was that HBB might open the airways more strongly, but would cause more unwanted effects, especially a faster heartbeat.

The horses received each medicine at different times, so each horse could be compared with itself rather than relying only on differences between horses. Airflow, gut sounds, and heart rate were checked before treatment and repeatedly afterward.

The airflow and gut assessments were made without knowing which medicine had been given. Both medicines improved the main signs of blocked airflow. Salbutamol continued improving one measure from five minutes through three hours, while HBB improved it only briefly, at ten and fifteen minutes.

A measure that worsens when the smaller airways are affected by asthma improved over time with both medicines. With salbutamol, the improvement was still present three hours later; with HBB, it lasted only from five to fifteen minutes. The heart rate increased only after HBB, and the increase lasted for thirty minutes.

Salbutamol did not produce the same heart-rate change. Gut sounds also decreased after HBB for thirty minutes, showing that this medicine affected intestinal movement as well. The same pattern was not seen with salbutamol. The results indicate that both salbutamol and HBB rapidly relieve blocked airflow in horses with severe asthma.

The two medicines had similar strength, but the airway-opening effect lasted longer with salbutamol: up to three hours instead of one hour with HBB, and without the unwanted effects seen with HBB. The study used the same drug dose for horses of different weights, which was a limitation of its practical treatment approach.

It also included relatively few horses after two were excluded, limiting statistical power and making some differences between the medicines harder to detect. So the result is useful, but it should be read with care: the study was designed to reflect practical treatment, while its small size limits how confidently every difference can be measured.

For short-term relief of narrowed airways in horses with asthma, the longer-lasting effect and the absence of heart and gut side effects suggest choosing salbutamol over HBB. For the people caring for these horses, that means a treatment may open the airways quickly while giving breathing relief more time to last, without adding the same concerns about the heart and intestines.

Both medicines relieved airway narrowing about equally quickly, but salbutamol lasted longer and did not produce the heart and gut effects seen with HBB. That makes it the more appealing short-term choice for horses with asthma.